Re: ... just for whatever reason...

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7750 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ... just for whatever reason...

in response to

Re: ... just for whatever reason...

Nextblockbuster

posted on Jan 20, 2019 12:38PM

NBB - I not suggesting that ZCC will be listed but may be listed. For the last number of years ZCC's documentation and accounting practices has been at the standards required for a NASDAQ listing. This allowed for that event to happen on a foundation that was put in place well in advance of being necessary if required. DM made this clear a couple of AGM's ago.